Plasma-derived therapy (Kedrion Biopharma)

N/A

Report date: 2025/12/05 17:17:14

Base Information

Drug NamePlasma-derived therapy (Kedrion Biopharma)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCongenital Aceruloplasminemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKedrion Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKedrion Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCongenital Aceruloplasminemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A